A year into the COVID-19 pandemic, scientists have learned a lot about the virus — and one major area of growth has been learning how best to treat patients who catch the virus.

Gilead Sciences’s remdesivir would be the first treatment to pass such a test against the virus, which has killed more than 218,000 people since it emerged late last year in China.